Zapping the Brain's memory network: a new hope for epilepsy?

NCT ID NCT06521437

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This pilot study at the University of Chicago is testing whether a non-invasive brain stimulation technique called TMS can improve memory and reduce seizure-related brain activity in people with mesial temporal lobe epilepsy (MTLE). Thirty-four adults with drug-resistant MTLE will receive TMS targeting a brain region connected to the hippocampus, which is key for memory. Researchers will measure changes in memory performance, brain activity, and seizure frequency before and after stimulation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

transcranial magnetic stimulation (TMS)

What this could lead to

If successful, this could point toward a non-invasive brain stimulation approach to improve memory and reduce seizure activity in epilepsy.

What could go wrong

This is a very small, early pilot study (34 people) with no randomization or blinding, so results may not be reliable or generalizable. The main goal is to understand brain function, not to test a treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MESIAL TEMPORAL LOBE EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

mesial temporal lobe epilepsy with hippocampal sclerosis temporal lobe epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Chicago

    Chicago, Illinois, 60637, United States